查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917901

胰岛素储存装置市场－2026-2031年预测

Insulin Storage Devices Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计胰岛素储存设备市场将从 2025 年的 907,697,000 美元增长到 2031 年的 1,445,265,000 美元，复合年增长率为 8.06%。

胰岛素储存设备市场是糖尿病照护生态系统中一个专业化且快速成长的细分市场，专注于提供温度控制解决方案，以维持胰岛素的稳定性和疗效。这些设备种类繁多，从简单的隔热外壳到复杂的电子冷却外壳，对于确保胰岛素这种温度敏感生物製药的疗效至关重要。妥善储存是有效糖尿病自我管理的基础组成部分，而市场成长与全球糖尿病盛行率的上升、对病患教育的日益重视、持续胰岛素输注系统的广泛应用以及人口老化等因素直接相关。

市场成长的主要驱动力是全球糖尿病（包括第1型和第2型糖尿病）盛行率的不断上升。随着需要外源性胰岛素治疗的患者人数增加，对可靠储存解决方案的绝对需求也随之增加。胰岛素对温度变化高度敏感，暴露于高温或冷冻环境会导致荷尔蒙劣化，使其失效并可能造成危险。因此，无论是在家中储存、旅行途中或日常携带，合适的储存环境都至关重要。庞大的糖尿病患者群体使得所有医疗机构对储存设备的需求持续且根本。

与这种流行病学趋势相呼应的是，人们越来越重视糖尿病的综合管理和病患教育。医疗服务提供者、倡议团体和公共卫生倡议日益强调正确胰岛素管理的重要性，认为这是治疗效果的基础。旨在提高患者意识、强调不当储存风险的宣传活动正在推动专用储存方案的普及。这种教育推广正在改变人们对胰岛素储存的看法，使其从可有可无转变为公认的必需品，并将市场从早期使用者扩展到更广泛的患者群体。

先进胰岛素输注技术（尤其是胰岛素帮浦和自动胰岛素输注系统）的日益普及是推动市场发展的关键因素。这些系统通常使用胰岛素储液器和药筒，使用前必须在稳定的温度下储存。接受胰岛素帮浦治疗的患者通常积极参与疾病管理，并且会投资购买辅助器具以坚持昂贵的治疗方法。储存备用胰岛素管瓶/笔和胰岛素帮浦耗材的需求催生了储液设备市场中一个特定的高端细分市场，该市场更青睐具有精确温度控制和可靠便携性的产品。

人口结构趋势，尤其是全球人口老化，进一步推动了市场成长。老年人在糖尿病患者中占很大比例，他们可能面临与药物管理相关的独特挑战，例如认知功能下降和居住环境温度控制不佳。这群人更需要一种安全有效的胰岛素储存解决方案，从而支撑了对便捷可靠的胰岛素储存设备的需求。

从区域来看，北美是主导且成熟的市场。这一地位得益于该地区糖尿病的高发病率、完善的糖尿病护理标准、较高的患者意识以及众多医疗器材製造商和糖尿病护理公司的强大实力。该地区先进的医疗保健基础设施和相对较高的可支配收入正在推动辅助护理产品的普及，其中包括一些专业的储存解决方案，即使这些解决方案并非完全由保险覆盖，也被视为健康管理的重要补充。

儘管存在这些强劲的驱动因素，市场也面临显着的限制。一个关键挑战是成本敏感性，尤其是在价格敏感的市场以及缺乏足够耐用医疗设备保险的患者群体中。先进的电子冷却设备可能导致高额的自付费用，从而限制了高所得和高需求人口的接受度。此外，市场也面临来自基础型低成本替代品的竞争。例如，一个简单的可重复使用冰袋的保温袋可能满足某些用户的基本需求，但它并不具备温度监测或主动冷却等高级功能。

产品种类繁多，从采用相变材料的被动式冷却外壳到配备电池供电和数位温度显示的电子主动冷却器，应有尽有。创新重点在于提升温度稳定性、延长电池寿命、增强便携性和耐用性，以及整合蓝牙连接等智慧功能以记录温度。竞争格局涵盖了糖尿病专业公司和众多消费级冷却产品製造商，他们主要在可靠性、认证（例如，在认证的时间内维持特定温度范围）、品牌信誉和易用性方面展开竞争。

总之，胰岛素储存设备市场虽然属于小众市场，但却是高品质糖尿病照护的重要组成部分，直接影响药物疗效和病人安全。其成长主要受结构性因素驱动：全球糖尿病发生率的显着上升以及由此产生的对生物製药妥善管理的需求。未来市场发展将受到以下因素的影响：能否提供兼具成本效益和高效能的解决方案；能否进一步与数位化糖尿病管理平台整合；以及能否设计出满足不同用户群（包括旅行者、活跃人士和老年人）特定需求的产品。随着糖尿病管理日益精细化和以患者为中心，可靠的胰岛素储存仍将是成功治疗的关键支柱。

本报告的主要优势：

  • 深入分析：获取主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨市场驱动因素和关键趋势，以及它们将如何影响未来的市场发展。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

报告的主要用途

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展动态）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 胰岛素储存装置市场（按类型划分）

  • 介绍
  • 胰岛素冷却器
  • 冷却袋
  • 胰岛素冷却袋
  • 冷却钱包

6. 依糖尿病类型分類的胰岛素储存设备市场

  • 介绍
  • 1型
  • 类型 2

7. 依最终用户分類的胰岛素储存设备市场

  • 介绍
  • 居家医疗环境
  • 医院
  • 专科诊所

8. 各地区胰岛素储存设备市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • DISONCARE
  • Medicool
  • Arkray, Inc.
  • Godrej Enterprise Group
  • FRIO
  • BreezyPacks
  • 4AllFamily
  • Axacool Insulin Cooling Case
  • Tempramed
  • INUTEQ

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615964

Insulin Storage Devices Market is projected to expand at a 8.06% CAGR, attaining USD 1445.265 million in 2031 from USD 907.697 million in 2025.

The insulin storage devices market is a specialized and growing segment within the broader diabetes care ecosystem, focused on providing temperature-controlled solutions to maintain the stability and potency of insulin. These devices, ranging from simple insulated carriers to advanced electronic cooling cases, are critical for ensuring the efficacy of insulin, a temperature-sensitive biologic. Proper storage is a fundamental component of effective diabetes self-management, and the market's expansion is directly linked to the rising global diabetes prevalence, increasing emphasis on patient education, the adoption of continuous insulin delivery systems, and demographic shifts toward an aging population.

The primary and most powerful driver of market growth is the escalating global prevalence of diabetes, both type 1 and type 2. As the number of individuals requiring exogenous insulin therapy increases, so does the absolute demand for reliable storage solutions. Insulin is highly sensitive to temperature extremes; exposure to heat or freezing can degrade the hormone, rendering it ineffective and potentially dangerous. This creates a non-negotiable need for appropriate storage, whether at home, during travel, or as part of daily carry. The sheer scale of the diabetic population establishes a substantial and sustained baseline demand for storage devices across all care settings.

Parallel to this epidemiological trend is the increasing focus on comprehensive diabetes management and patient education. Healthcare providers, advocacy groups, and public health initiatives are placing greater emphasis on the importance of proper insulin handling as a cornerstone of treatment efficacy. Educational campaigns that highlight the risks of improper storage are raising patient awareness and driving the adoption of dedicated storage solutions. This educational push is transforming storage from an afterthought into a recognized essential, thereby expanding the market beyond early adopters to a broader patient base.

The growing adoption of advanced insulin delivery technologies, particularly insulin pumps and automated insulin delivery (AID) systems, is a significant catalyst for the market. These systems often utilize insulin reservoirs or cartridges that must be kept at stable temperatures before use. Patients on pump therapy are typically highly engaged in their disease management and invest in supporting accessories to protect their expensive therapy. The need to store both backup insulin vials/pens and pump supplies creates a specific and often premium segment within the storage device market, favoring products with precise temperature control and reliable portability.

Demographic trends, specifically the aging of the global population, further underpin market growth. Older adults represent a large proportion of the diabetic population and may face unique challenges related to medication management, including potential cognitive decline or living situations without consistent climate control. This demographic is more likely to benefit from and potentially require explicit solutions for safe insulin storage, supporting demand for user-friendly, reliable devices.

Geographically, North America represents a leading and mature market. This position is supported by a high prevalence of diabetes, well-established diabetes care standards, high patient awareness, and a strong presence of device manufacturers and diabetes care companies. The region's advanced healthcare infrastructure and relatively high disposable income facilitate the adoption of supportive care products, including specialized storage solutions that may not be fully reimbursed but are viewed as valuable for health management.

Despite strong drivers, the market faces notable restraints. A key challenge is cost sensitivity, particularly in price-conscious markets and for patients without adequate insurance coverage for durable medical equipment. Advanced electronic cooling devices can represent a significant out-of-pocket expense, potentially limiting adoption to higher-income segments or those with strong perceived need. Additionally, the market contends with competition from basic, low-cost alternatives like simple insulated bags with reusable ice packs, which may satisfy minimum requirements for some users despite lacking advanced features like temperature monitoring or active cooling.

The product landscape ranges from passive cooling cases utilizing phase-change materials to active electronic coolers with battery power and digital temperature displays. Innovation focuses on improving temperature stability, extending battery life, enhancing portability and durability, and integrating smart features such as Bluetooth connectivity for temperature logging. The competitive environment includes dedicated diabetes supply companies and broader consumer cooling product manufacturers, competing on reliability, certification (e.g., maintaining a specific temperature range for a certified duration), brand trust, and ease of use.

In conclusion, the insulin storage devices market, while niche, is an essential component of quality diabetes care, directly supporting medication efficacy and patient safety. Its growth is structurally supported by the undeniable rise in global diabetes incidence and the corresponding imperative for proper biologic drug stewardship. Future market development will be influenced by the ability to offer cost-effective yet high-performance solutions, further integration with digital diabetes management platforms, and designs that cater to the specific needs of diverse user groups, including travelers, active individuals, and the elderly. As diabetes management becomes increasingly sophisticated and patient-centered, reliable insulin storage will remain a fundamental, if often overlooked, pillar of successful treatment outcomes.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Insulin Storage Devices Market Segmentation

  • By Type
  • Insulin Coolers
  • Cooling Pouches
  • Insulin Cooling Bags
  • Cooling Wallets
  • By Diabetes Type
  • Type 1
  • Type 2
  • By End-User
  • Homecare Settings
  • Hospitals
  • Specialty Clinics
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. INSULIN STORAGE DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Insulin Coolers
  • 5.3. Cooling Pouches
  • 5.4. Insulin Cooling Bags
  • 5.5. Cooling Wallets

6. INSULIN STORAGE DEVICES MARKET BY DIABETES TYPE

  • 6.1. Introduction
  • 6.2. Type 1
  • 6.3. Type 2

7. INSULIN STORAGE DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Homecare Settings
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. INSULIN STORAGE DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. DISONCARE
  • 10.2. Medicool
  • 10.3. Arkray, Inc.
  • 10.4. Godrej Enterprise Group
  • 10.5. FRIO
  • 10.6. BreezyPacks
  • 10.7. 4AllFamily
  • 10.8. Axacool Insulin Cooling Case
  • 10.9. Tempramed
  • 10.10. INUTEQ

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations